Investors

Webcast ImageWebcast - Live
Q2 2016 OraSure Technologies, Inc. Earnings Conference Call
08/03/16 at 5:00 p.m. ET
Q2 2016 OraSure Technologies, Inc. Earnings Conference Call
Wednesday, August 3, 2016 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
Fact Sheet - PDF Fact Sheet
2015 Annual Report on Form 10-K - PDF 2015 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$6.82
Change (%) Stock is Up 0.23 (3.49%)
Volume615,496
Data as of 07/29/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
07/13/16OraSure Technologies Earnings Conference Call Invitation
2016 Second Quarter Earnings Conference Call Wednesday, August 3, 2016, 5:00 p.m. ET BETHLEHEM, Pa., July 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 second quarter financial results, 2016 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 3, 2016.      August 3, 2016 Schedule       ... 
Printer Friendly Version
07/01/16OraSure Technologies and AbbVie Agree to an Early Termination of HCV Co-Promotion Agreement
Investor Conference Call Scheduled Today at 8:30 a.m. Eastern Time BETHLEHEM, Pa., July 01, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies (NASDAQ:OSUR), a market leader in point of care diagnostics, announced today that OraSure Technologies and AbbVie have mutually agreed to an early termination of their Master Program Services and Co-Promotion Agreement under which the companies have been co-promoting OraSure’s OraQuick® HCV Rapid Antibody Test in the United States. The agreement was origina... 
Printer Friendly Version
06/30/16OraSure Technologies Investor Call Invitation
Investor Conference Call July 1, 2016, 8:30 a.m. ET BETHLEHEM, Pa., June 30, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled an investor conference call and simultaneous webcast for 8:30 a.m. ET (5:30 a.m. PT) on July 1, 2016 to provide an update on the Company’s HCV business and certain other developments. July 1, 2016 Schedule 8:20 a.m. ET To participate in the conference call, dial 844-831-3030 (Domestic) or 315-625-6887 (International) and reference ... 
Printer Friendly Version
05/31/16OraSure Technologies to Present at the Jefferies 2016 Healthcare Conference
BETHLEHEM, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2016 Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak June 8, 2016, at approximately 8:30 AM Eastern Time (5:30 AM Pacific Time).  Interested investors can access the live webcast of the presentation by goi... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
08/03/16 5:00 p.m. ET
Q2 2016 OraSure Technologies, Inc. Earnings Conference Call
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet